Previous studies have shown that DYRK1B inhibition can ameliorate endothelial dysfunction (Pramotton et al., 2023) and chronic inflammatory diseases (Ciurus et al., 2025). The gene discussed is DYRK1B; the disease is endothelial dysfunction.